Every investor eventually reaches that moment, staring at a stock chart, unsure what to do next.
Sometimes the stock is falling. Other times it has climbed and delivered solid gains. In either case, the same question tends to surface: How do I know when to sell?
I have been asked this question in almost every investing class I have taught. Again and again, what I have found is that too many investors are caught flat-footed. Not because they do not understand the company, but because they never clearly defined why they owned it in the first place.
Without that clarity, every dip feels like danger, and every rally feels like a signal to lock in gains. That is when emotion takes over, and poor decisions follow.
What is needed is a lighthouse to guide the way. A compass that provides direction. In investing, that compass is a thesis. A clear thesis provides a reasoned foundation for every decision. It serves as the reminder during volatility that brings conviction.
While there are several valid reasons to sell (which will be addressed later), when all else is equal, the thesis should remain the primary guide. It ensures logic stays in control, leading to better, more consistent outcomes.
What Is an Investment Thesis?
Simply put, a thesis answers the question: Why do I own this stock?
A thesis does not have to be complicated, but it should be thoughtful. If it’s based on hype, borrowed ideas, or vague hope, it will not help when things get tough.
Importantly, a good thesis is not exclusive to long-term investing. Momentum traders often use one tied to price action or catalysts. Value investors use discounted cash flow models or margin of safety thresholds. But for long-term investors, especially those focused on compounding quality over time, the thesis allows for patience and discipline.
My investing approach centers around quality compounders. These are companies with strong free cash flow, durable competitive advantages, and disciplined capital allocation. Therefore, a thesis is that compass that dictates when it is time to sell. For example, when volatility hits, or headlines turn negative, the thesis gives me something to measure against. It has given me the conviction to hold during scary times over the years, as well as determine when it is time to part ways with a name.
A Four-Part Framework for Building a Stock Thesis
Let me share my process for developing a thesis, which I have refined through years of trial and error. It follows a four-part structure based on the criteria I use to identify quality compounders:
☐ Business Quality: How consistent is the company’s ability to generate cash? Is the model simple and repeatable? I evaluate predictable free cash flow, high returns on invested capital, and resilience across business cycles. Strong reinvestment supports predictable growth and long-term value creation, especially when return on capital exceeds the cost of capital.
☐ Moat: Does the company have an advantage that protects it from competition, such as brand strength, scale, switching costs, or regulatory insulation? Without a moat, growth is perceived as temporary.
☐ Capital Allocation: What does management do with the cash it generates? Do they reinvest productively or pursue distractions? Poor capital allocation can destroy value, even in strong businesses. I look for management teams that deploy capital effectively to sustain or grow economic value added.
☐ Strategic Fit: Does the company align with my investing goals, including at a valuation that provides a margin of safety and supports long-term compounding? I prefer resilient businesses that do not require constant monitoring and fit my quality-focused, long-term style.
When all four align, I am interested and confident. I then distill the analysis into a clear thesis statement that summarizes the reason for owning the stock. This provides an anchor during times of market volatility.
🠖 You can find a more detailed framework for how I evaluate stocks in My Investing Philosophy.
Example of a Working Thesis: Thermo Fisher Scientific
Here is a real thesis from my portfolio. One of my most recent additions to my portfolio is Thermo Fisher Scientific (TMO). My reason for buying the company is grounded in its durable characteristics. This is a quality compounder that reflects the four-part framework I use to evaluate long-term holdings.
Thesis Statement: I own Thermo Fisher because it is a resilient life sciences leader with recurring revenues ensuring predictable cash flows, scale and acquisition-driven one-stop shop model creating a wide moat, disciplined capital allocation fueling growth, and alignment with my goal of holding compounding businesses through cycles at a reasonable valuation.
Breaking down the framework:
✅ Business Quality: Thermo Fisher generates consistent free cash flow through recurring revenue from consumables and services tied to drug development, diagnostics, and research. Its diversified operations support strong returns on capital and predictable performance through economic cycles.
✅ Moat: Its moat is rooted in scale, switching costs, and integration across their customers workflow. The company serves pharmaceutical, biotech, and academic institutions with a broad suite of offerings, which makes it difficult for clients to replace or replicate its services. This provides pricing power and customer stickiness.
✅ Capital Allocation: Management has shown discipline in its use of capital, using strategic acquisitions such as Patheon and PPD to expand capabilities without compromising financial quality. These deals have added meaningful scale and been integrated without damaging returns.
✅ Strategic Fit: Thermo Fisher fits my long-term approach. It is exposed to secular growth drivers like aging demographics and biotech innovation. The business requires limited intervention once owned and benefits from scale-driven reinvestment. Following a significant pullback, shares now trade at a compelling valuation that provides a margin of safety and supports long-term compounding.
Going forward, I will gauge price movements through the lens of this thesis to make decisions. As long as everything remains intact, pullbacks can be viewed as opportunities to build the position. That is the power of a clearly defined thesis.
When to Sell (And When to Hold Your Ground)
Once a thesis is in place, it becomes that compass that guides my actions. Especially during uncertainty, it can help answer that familiar question: is it time to sell? Again, we want to avoid letting emotion take over and instead make reasoned, deliberate choices based on the thesis.
Here are a few signs it may be time to sell:
- The thesis breaks. The business begins to deteriorate, its competitive advantages are called into question, or management starts making questionable decisions. This is the clearest signal to act.
- The thesis plays out. Sometimes a stock runs ahead of its fundamentals. If the core drivers of the thesis have already delivered, trimming can be a smart way to lock in gains and maintain discipline.
- The thesis was flawed. Sometimes, you just get it wrong despite the due diligence to draft a thoughtful thesis. Maybe you misjudged the moat, or the management team underdelivered. It is better to acknowledge the mistake than cling to a broken idea.
There are also sell decisions that have nothing to do with the company itself. It is worth acknowledging these situational but valid reasons to sell:
- Portfolio discipline. As positions grow, it may reach uncomfortable levels within a portfolio. Even the best company carries risks warranting concerns of over-concentration.
- Personal shifts. Life changes, therefore, so does risk tolerance, time horizon, or liquidity needs. Selling in these cases is not weakness. It is being practical.
- Valuation limits. A great business is not always a great investment. If the stock trades well beyond what its growth and reinvestment potential can justify, reducing or exiting may be the right move.
As a long-term investor, I tend to lean toward letting winners run. That is how compounding works. And so, while these are other reasons that might justify selling, I place the highest weight on the investment thesis. If the thesis is intact, I am inclined to hold. I enter positions with this mindset, and the framework I use to develop the thesis reinforces that discipline.
When to Reevaluate Thermo Fisher
Let us revisit Thermo Fisher. If the company began making acquisitions that no longer strengthened its core capabilities, or if it started to lose pricing power due to competition or weaker customer relationships, I would begin to question the thesis. I would also take notice of any signs of strategic drift, deteriorating execution, or ineffective use of capital. These are the types of changes that would challenge my original conviction and prompt a closer evaluation of whether the business still fits within my long-term framework.
Valuation also matters. If the stock were to trade far above what its fundamentals justify, especially relative to growth expectations and reinvestment opportunities, I would likely consider trimming the position. That is not because the business has failed, but because the price no longer supports the compounding runway I am looking for.
Still, if the core business remains intact, the competitive advantages hold firm, and the valuation continues to offer room for long-term compounding, I will hold. Thermo Fisher is the type of company I want to own through market cycles. The thesis is what helps me stay grounded. It keeps me focused when the market gets noisy and allows me to act with clarity rather than emotion.
Final Thought
Investing is full of noise. That noise plays on emotions and clouds judgment. Without conviction, it becomes far too easy to react to fear rather than reason.
A clear thesis filters out distractions and brings the focus back to what truly matters. It provides a consistent guide for navigating uncertainty, and helps frame both buying and selling decisions in a logical way.
No thesis will eliminate mistakes, but a well-constructed one can prevent many of the worst ones. Build it carefully. Refer to it often. Let it guide decisions when things become uncomfortable.
At the end of the day, the real edge in investing is not about finding the next big thing. It is about knowing why a stock is in the portfolio and having the discipline to act when that reason no longer holds. That clarity can turn emotional moments into confident, thoughtful actions. This will be particularly valuable when deciding whether to sell.
Disclosure: I have a long equity position in Thermo Fisher Scientific (TMO).
🠔
Want more? Check out other articles
🠖
- Reddit Stock: Unproven Today, Worth Watching Tomorrow
- How Warren Buffett’s Letters Shaped My Investment Philosophy
- How Stock Investors Benefit from Compounding
